223 related articles for article (PubMed ID: 36920663)
1. DNA methylation provides diagnostic value for meningioma recurrence in clinical practice.
Shen E; Leclair NK; Herlth K; Soucy M; Renzette N; Zhuo X; Kelly K; Omerza G; Onyiuke H; McNeill I; Wolansky L; Becker K; Li L; Wu Q; Bulsara KR
Acta Neurochir (Wien); 2023 May; 165(5):1323-1331. PubMed ID: 36920663
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Sahm F; Schrimpf D; Stichel D; Jones DTW; Hielscher T; Schefzyk S; Okonechnikov K; Koelsche C; Reuss DE; Capper D; Sturm D; Wirsching HG; Berghoff AS; Baumgarten P; Kratz A; Huang K; Wefers AK; Hovestadt V; Sill M; Ellis HP; Kurian KM; Okuducu AF; Jungk C; Drueschler K; Schick M; Bewerunge-Hudler M; Mawrin C; Seiz-Rosenhagen M; Ketter R; Simon M; Westphal M; Lamszus K; Becker A; Koch A; Schittenhelm J; Rushing EJ; Collins VP; Brehmer S; Chavez L; Platten M; Hänggi D; Unterberg A; Paulus W; Wick W; Pfister SM; Mittelbronn M; Preusser M; Herold-Mende C; Weller M; von Deimling A
Lancet Oncol; 2017 May; 18(5):682-694. PubMed ID: 28314689
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma.
Vasudevan HN; Castro MRH; Lee JC; Villanueva-Meyer JE; Bush NAO; McDermott MW; Solomon DA; Perry A; Magill ST; Raleigh DR
Acta Neuropathol Commun; 2020 Jun; 8(1):82. PubMed ID: 32517746
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic Profiling Revealed Lnc-GOLGA6A-1 as a Novel Prognostic Biomarker of Meningioma Recurrence.
Slavik H; Balik V; Kokas FZ; Slavkovsky R; Vrbkova J; Rehulkova A; Lausova T; Ehrmann J; Gurska S; Uberall I; Hajduch M; Srovnal J
Neurosurgery; 2022 Aug; 91(2):360-369. PubMed ID: 35551164
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic changes underlie the aggressiveness of histologically benign meningiomas that recur.
San-Miguel T; Navarro L; Megías J; Muñoz-Hidalgo L; Gil-Benso R; Roldán P; López-Ginés C; Cerdá-Nicolás M
Hum Pathol; 2019 Feb; 84():105-114. PubMed ID: 30261191
[TBL] [Abstract][Full Text] [Related]
6. DNA methylation profiling of meningiomas highlights clinically distinct molecular subgroups.
Singh J; Sharma R; Shukla N; Narwal P; Katiyar A; Mahajan S; Sahu S; Garg A; Sharma MC; Suri A; Sarkar C; Suri V
J Neurooncol; 2023 Jan; 161(2):339-356. PubMed ID: 36564673
[TBL] [Abstract][Full Text] [Related]
7. Global epigenetic profiling identifies methylation subgroups associated with recurrence-free survival in meningioma.
Olar A; Wani KM; Wilson CD; Zadeh G; DeMonte F; Jones DT; Pfister SM; Sulman EP; Aldape KD
Acta Neuropathol; 2017 Mar; 133(3):431-444. PubMed ID: 28130639
[TBL] [Abstract][Full Text] [Related]
8. Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas.
Barciszewska AM
BMC Cancer; 2020 Jun; 20(1):509. PubMed ID: 32493231
[TBL] [Abstract][Full Text] [Related]
9. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.
Di Vinci A; Brigati C; Casciano I; Banelli B; Borzì L; Forlani A; Ravetti GL; Allemanni G; Melloni I; Zona G; Spaziante R; Merlo DF; Romani M
Transl Res; 2012 Nov; 160(5):355-62. PubMed ID: 22735029
[TBL] [Abstract][Full Text] [Related]
10. Molecular biological determinations of meningioma progression and recurrence.
Linsler S; Kraemer D; Driess C; Oertel J; Kammers K; Rahnenführer J; Ketter R; Urbschat S
PLoS One; 2014; 9(4):e94987. PubMed ID: 24722350
[TBL] [Abstract][Full Text] [Related]
11. Clonal cytogenetic progression within intratumorally heterogeneous meningiomas predicts tumor recurrence.
Urbschat S; Rahnenführer J; Henn W; Feiden W; Wemmert S; Linsler S; Zang KD; Oertel J; Ketter R
Int J Oncol; 2011 Dec; 39(6):1601-8. PubMed ID: 21922133
[TBL] [Abstract][Full Text] [Related]
12. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
[TBL] [Abstract][Full Text] [Related]
13. Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies.
Bayley JC; Hadley CC; Harmanci AO; Harmanci AS; Klisch TJ; Patel AJ
Sci Adv; 2022 Feb; 8(5):eabm6247. PubMed ID: 35108039
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management.
Nassiri F; Mamatjan Y; Suppiah S; Badhiwala JH; Mansouri S; Karimi S; Saarela O; Poisson L; Gepfner-Tuma I; Schittenhelm J; Ng HK; Noushmehr H; Harter P; Baumgarten P; Weller M; Preusser M; Herold-Mende C; Tatagiba M; Tabatabai G; Sahm F; von Deimling A; ; Zadeh G; Aldape KD
Neuro Oncol; 2019 Jul; 21(7):901-910. PubMed ID: 31158293
[TBL] [Abstract][Full Text] [Related]
15. Molecular alterations in meningiomas: Literature review.
Pereira BJA; Oba-Shinjo SM; de Almeida AN; Marie SKN
Clin Neurol Neurosurg; 2019 Jan; 176():89-96. PubMed ID: 30553171
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic and genomic profiling of chordoid meningioma: implications for clinical management.
Daoud EV; Zhu K; Mickey B; Mohamed H; Wen M; Delorenzo M; Tran I; Serrano J; Hatanpaa KJ; Raisanen JM; Snuderl M; Cai C
Acta Neuropathol Commun; 2022 Apr; 10(1):56. PubMed ID: 35440040
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of genetic alterations and methylation classes in meningioma.
Berghoff AS; Hielscher T; Ricken G; Furtner J; Schrimpf D; Widhalm G; Rajky U; Marosi C; Hainfellner JA; von Deimling A; Sahm F; Preusser M
Brain Pathol; 2022 Mar; 32(2):e12970. PubMed ID: 35213082
[TBL] [Abstract][Full Text] [Related]
18. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma.
Paramasivam N; Hübschmann D; Toprak UH; Ishaque N; Neidert M; Schrimpf D; Stichel D; Reuss D; Sievers P; Reinhardt A; Wefers AK; Jones DTW; Gu Z; Werner J; Uhrig S; Wirsching HG; Schick M; Bewerunge-Hudler M; Beck K; Brehmer S; Urbschat S; Seiz-Rosenhagen M; Hänggi D; Herold-Mende C; Ketter R; Eils R; Ram Z; Pfister SM; Wick W; Weller M; Grossmann R; von Deimling A; Schlesner M; Sahm F
Acta Neuropathol; 2019 Aug; 138(2):295-308. PubMed ID: 31069492
[TBL] [Abstract][Full Text] [Related]
19. Meningiomas: loss of heterozygosity on chromosome 10 and marker-specific correlations with grade, recurrence, and survival.
Mihaila D; Jankowski M; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
Clin Cancer Res; 2003 Oct; 9(12):4443-51. PubMed ID: 14555517
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.
Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T
Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
